SeaSpine Gains FDA Clearance for Amended Indication for NanoMetalene Surface Technology

SeaSpine received FDA 510(k) clearance to market its NanoMetalene® surface technology with amended indications.

NanoMetalene surface technology for interbody devices incorporates a submicron layer of commercially pure titanium molecularly bonded to a PEEK implant using a high-energy, low-temperature process. It provides a molecularly...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.

Contact Us